Network-based approaches for drug response prediction and targeted therapy development in cancer

Area of Science:

• Computational systems biology
• Cancer research
• Precision medicine

Background:

• Cancer signaling pathways are complex, featuring regulatory loops and redundancy.
• This complexity leads to treatment failure and drug resistance, challenging the one-drug-one-target approach.
• Robust cancer networks require advanced therapeutic strategies beyond single-agent treatments.

Purpose of the Study:

• To review the state-of-the-art in targeted cancer medicine from a computational systems biology viewpoint.
• To explore the integration of high-throughput patient data with biological signaling information for personalized treatment.
• To identify effective combination therapies for overcoming cancer drug resistance.

Main Methods:

• Review of major biological signaling network resources and their characteristics.
• Discussion of computational methods for predicting drug sensitivity using signaling networks and high-throughput data.
• Analysis of approaches for suggesting intervention combinations based on patient-specific molecular patterns.

Main Results:

• Signaling network resources vary in their applicability for drug response prediction and target identification.
• Computational methods can predict drug sensitivity and suggest combination interventions when integrated with patient data.
• Systems biology approaches offer a framework for deciphering patient-specific molecular patterns.

Conclusions:

• Combination therapy is essential for overcoming the robustness of cancer signaling networks.
• Integrating patient data with signaling networks enables personalized medicine and improved therapeutic targeting.
• Clinical integration of these computational approaches will enhance treatment response prediction and intervention strategies.